米国企業
BIO-TECHNE Corp

BIO-TECHNE CorpTECH

時価総額

$131.7億

PER

58.8倍

	2012年 6月30日	2013年 6月30日	2014年 6月30日	2015年 6月30日	2016年 6月30日	2017年 6月30日	2018年 6月30日	2019年 6月30日	2020年 6月30日	2021年 6月30日	2022年 6月30日	2023年 6月30日
Cash and cash equivalents	117	164	319	55	64	92	122	101	147	199	173	181
Short-term Investments	-	-	-	-	-	-	-	-	-	-	-	24
Accounts Receivable, after Allowance for Credit Loss, Current	36	38	48	70	93	117	120	137	123	145	195	218
Inventories	38	35	39	50	57	60	86	91	103	117	141	172
Other current assets	-	-	-	6	8	13	11	18	24	17	23	27
Total current assets	347	410	469	248	254	348	398	413	521	511	606	621
Property and equipment, net	94	109	117	130	132	135	145	154	177	208	223	226
Right of use asset	-	-	-	-	-	-	-	-	71	74	66	98
Goodwill	86	84	151	391	431	579	598	733	728	843	822	873
Intangible assets, net	-	-	-	-	-	452	446	579	517	616	532	535
Other assets	2	2	2	2	2	44	5	6	14	12	47	285
Total assets	719	778	862	1,063	1,130	1,558	1,593	1,884	2,028	2,263	2,295	2,639
Trade accounts payable	6	6	10	13	21	17	18	16	23	29	34	26
Salaries, wages and related accruals	5	4	6	10	15	27	24	29	31	51	62	37
Accrued expenses	7	10	4	7	8	19	21	26	9	15	18	15
Contract liabilities	-	-	-	-	-	-	-	9	13	19	23	23
Income taxes payable	3	2	0	2	2	2	9	6	2	5	13	12
Operating lease liabilities - current	-	-	-	-	-	-	-	-	10	12	12	11
Contingent consideration payable	-	-	-	-	-	65	-	3	6	4	-	4
Current portion of long-term debt obligations	-	-	-	-	-	-	-	13	13	13	13	-
Other current liabilities	-	-	-	-	-	-	-	-	-	4	1	1
Total current liabilities	36	32	26	40	54	136	80	102	107	152	176	129
Deferred income taxes	-	-	-	-	-	-	-	-	101	93	99	89
Long-term debt obligations	-	-	-	73	92	344	339	493	344	329	243	350
Long-term contingent consideration payable	-	-	-	39	39	3	-	9	0	25	5	-
Operating lease liabilities	-	-	-	-	-	-	-	-	67	68	58	94
Other long-term liabilities	-	-	-	3	3	5	9	25	27	24	12	11
Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding	-	-	-	-	-	-	-	-	-	-	-	-
Common Stock, Value, Issued	0	0	0	371,000	372,000	0	0	0	0	0	0	2
Additional paid-in capital	132	135	147	163	179	199	247	317	421	534	654	722
Retained earnings	520	588	653	714	771	799	877	932	1,057	1,085	1,123	1,309
Accumulated other comprehensive loss	22	15	-5	-31	-70	-49	-45	-84	-97	-57	-75	-66
Total Bio-Techne's shareholders' equity	674	738	795	847	879	950	1,079	1,166	1,381	1,571	1,702	1,967
Noncontrolling interest	-	-	-	-	-	-	-	-	-	8	-1	-
Total shareholders' equity	-	-	-	-	-	-	-	-	-	1,571	1,701	1,967
Total liabilities and shareholders' equity	719	778	862	1,063	1,130	1,558	1,593	1,884	2,028	2,263	2,295	2,639